English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China Contributions: (I) Conception and design: T Xia; (II) Administrative support: X Liu; (III) Provision of study materials or patients: G Ma, J Wang; (IV) Collection and assembly of data: H Zeng, JS Veeramootoo; (V) Data analysis and interpretation: Y Jiang, JS Veeramootoo; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. These authors contributed equally to this work. Correspondence to: Prof. Dr. Xiaoan Liu; Prof. Dr. Tiansong Xia. Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China. Email: liuxiaoan@126.com; xiatsswms@163.com.

Clinical value and feasibility of ISET in detecting circulating tumor cells in early breast cancer